Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Adami

Showing results (171-180 of 212) with videos related to

Pageof 22
Sort By:
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|June 7, 2000
Efficacy and safety of daily risedronate in the treatment of corticosteroid-induced osteoporosis in men and women: a randomized trial. European Corticosteroid-Induced Osteoporosis Treatment StudyD M Reid, R A Hughes, R F Laan, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|January 4, 2003
The effect of teriparatide [human parathyroid hormone (1-34)] therapy on bone density in men with osteoporosisE S Orwoll, W H Scheele, S Paul, et al.
The New England Journal of Medicine|September 9, 2000
Alendronate for the treatment of osteoporosis in menE Orwoll, M Ettinger, S Weiss, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|June 25, 2005
Association of quantitative heel ultrasound with history of osteoporotic fractures in elderly men: the ESOPO studyM Varenna, L Sinigaglia, S Adami, et al.
The Pharmacogenomics Journal|July 8, 2015
The -308 TNFα and the -174 IL-6 promoter polymorphisms associate with effective anti-TNFα treatment in seronegative spondyloarthritisM Fabris, L Quartuccio, C Fabro, et al.
Aging (Milan, Italy)|February 1, 2002
Tolerability of risedronate in postmenopausal women intolerant of alendronateJ D Adachi, S Adami, P D Miller, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|October 31, 2007
Fracture incidence and changes in quality of life in women with an inadequate clinical outcome from osteoporosis therapy: the Observational Study of Severe Osteoporosis (OSSO)C Cooper, F Jakob, C Chinn, et al.
Annals of the Rheumatic Diseases|October 30, 2007
Effects of strontium ranelate on spinal osteoarthritis progressionO Bruyere, D Delferriere, C Roux, et al.
Reumatismo|July 11, 2006
[Antinflammatory therapy and cardiovascular risk: a consensus view]D Gatti, S Adami, B Canesi, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|June 12, 2012
Osteoporosis in young adults: pathophysiology, diagnosis, and managementS Ferrari, M L Bianchi, J A Eisman, et al.
Pageof 22

Showing results (171-180 of 212) with videos related to

Sort By:
Pageof 22
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|June 7, 2000
Efficacy and safety of daily risedronate in the treatment of corticosteroid-induced osteoporosis in men and women: a randomized trial. European Corticosteroid-Induced Osteoporosis Treatment StudyD M Reid, R A Hughes, R F Laan, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|January 4, 2003
The effect of teriparatide [human parathyroid hormone (1-34)] therapy on bone density in men with osteoporosisE S Orwoll, W H Scheele, S Paul, et al.
The New England Journal of Medicine|September 9, 2000
Alendronate for the treatment of osteoporosis in menE Orwoll, M Ettinger, S Weiss, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|June 25, 2005
Association of quantitative heel ultrasound with history of osteoporotic fractures in elderly men: the ESOPO studyM Varenna, L Sinigaglia, S Adami, et al.
The Pharmacogenomics Journal|July 8, 2015
The -308 TNFα and the -174 IL-6 promoter polymorphisms associate with effective anti-TNFα treatment in seronegative spondyloarthritisM Fabris, L Quartuccio, C Fabro, et al.
Aging (Milan, Italy)|February 1, 2002
Tolerability of risedronate in postmenopausal women intolerant of alendronateJ D Adachi, S Adami, P D Miller, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|October 31, 2007
Fracture incidence and changes in quality of life in women with an inadequate clinical outcome from osteoporosis therapy: the Observational Study of Severe Osteoporosis (OSSO)C Cooper, F Jakob, C Chinn, et al.
Annals of the Rheumatic Diseases|October 30, 2007
Effects of strontium ranelate on spinal osteoarthritis progressionO Bruyere, D Delferriere, C Roux, et al.
Reumatismo|July 11, 2006
[Antinflammatory therapy and cardiovascular risk: a consensus view]D Gatti, S Adami, B Canesi, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|June 12, 2012
Osteoporosis in young adults: pathophysiology, diagnosis, and managementS Ferrari, M L Bianchi, J A Eisman, et al.
Pageof 22